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Results: Following ACL section, limb impairment rapidly devel-
oped in all dogs, with PVF and GCA values dropping by week
4. After this acute disability phase, the dogs underwent a slow
remission phase that was still incomplete by week 26. Prediction
of PVF change was best estimated (R2=0.96) from GCA and BML-
SPGR (p<0.0001), particularly during the phase of acute disability,
whereas cartilage defect was more inﬂuential (R2=0.97) during the
remission phase (p=0.0051) (week 8 to week 26). The other joint
structural damages had insigniﬁcant effect on limb impairment and
recovery. Both BML-SPGR and cartilage defect adversely affected
the recovery in PVF, with mutually independent effects.
Similar to ln_PVF, GCA showed an acute drop by week 4, followed
afterwards by a remission phase (p<0.0001), which attained base-
line values by week 26 (p=0,46). The time-course of GCA recovery
was negatively affected by cartilage defect, and was positively af-
fected by joint effusion (p<0.0001 for both variables).
Conclusions: In recent human OA studies, pain and limb im-
pairment were related mostly to BML and joint effusion. Our data
from dogs with experimental OA conﬁrms the role of BML and
joint effusion on limb function. On one hand, BML and carti-
lage defect hinder the recovery of PVF. On the other hand, joint
effusion positively inﬂuences GCA, supporting the existence of
alleviating mechanisms that oppose to abnormal biomechanics.
This study also clariﬁes the role of cartilage and other joint struc-
tural components in OA: cartilage volume and osteophytosis act
as confounding factors with negligible role in limb impairment.
Such structure/function modeling opens promising avenues for as-
sessing outcome of disease-modifying OA drugs at the preclinical
development stage.
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Purpose: The purpose of the study was to evaluate the efﬁcacy
of an ADAMTS-4 and ADAMTS-5 selective inhibitor in a robust
animal model of osteoarthritis (OA).
Methods: All animal studies were performed after IACUC ap-
proval. Male Lewis rats (20 per group) underwent medial meniscal
tear surgery in the right knee joint1. Rats were treated twice daily
by oral gavage with vehicle, selective ADAMTS-4/-5 inhibitor (ASI)
(10, 30, or 100 mg/kg) or a broad-spectrum MMP inhibitor (30
mg/kg), All treatments were initiated 1 day before surgery and
continued for 13 weeks. At the end of the dosing period, rats
were evaluated for normal mobility and plasma was taken for
pharmacokinetic analysis. Weight-bearing on the operated right
leg and contra-lateral left leg was evaluated in the vehicle-treated
and 30 mg/kg ASI-treated groups using an incapacitance meter,
and expressed as grams difference in weight bearing between
right and left leg. Following euthanasia, right knees were collected
for histopathology evaluation including subjective and objective
measures of cartilage degeneration and measures of joint capsule
thickening.
Results: Statistically signiﬁcant decreases in cartilage degenera-
tion scores and width of severe lesions were observed in animals
treated with both 30 and 100 mg/kg BID ASI. No adverse events
were observed in animals treated with any dose of ASI. Broad-
spectrum MMP inhibitor treatment resulted in decreased histologic
evidence of cartilage degradation, but also caused a 40% thick-
ening of the medial joint capsule, 6% lower body weight and a
reluctance to mobilize. The vehicle-treated animals demonstrated
a 27±2 grams decrease in weight bearing on the operated com-
pared to the control limb, while the animals treated with 30 mg/kg
SI had only a 16±2 grams decrease in weight bearing. This 41%
increase in relative weight bearing on the unstable knee was
statistically signiﬁcant.
Conclusions: This study demonstrated that the signiﬁcant reduc-
tion in cartilage degradation following surgical induction of joint
instability observed in gene-deleted ADAMTS-5 and ADAMTS-4/5
mice can also be produced by small molecule inhibition of en-
zyme activity. There were no adverse physiologic effects following
systemic inhibition of ADAMTS-4/5 activity for 13 weeks. The nor-
malization of weight-bearing, after treatment with an efﬁcacious
dose of ASI, indicated that decreasing cartilage degradation as
a result of inhibition of Aggrecanase-mediated aggrecan degra-
dation, positively affected stance and pain. These results support
this strategy of selective ADAMTS-4/5 inhibition as a safe and
effective method of disease modiﬁcation and pain modiﬁcation of
osteoarthritis, and should be evaluated in the clinic.
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Purpose: To evaluate gait pattern recorded on the CatWalk and
pain behaviour in two different rat models of osteoarthritis (OA).
Methods: Twenty-two male Sprague-Dawley rats weighing
200±25g were studied. Two weeks prior to the induction of OA,
animals were trained on the CatWalk runway (Noldus) to traverse
the corridor uninterruptedly. Mechanical allodynia was assessed
by measurement of withdrawal thresholds in response to appli-
cation of von Frey ﬁlaments. During the second week of the
training period, data were collected to obtain baseline values.
One group of rats (n=8) underwent surgical anterior cruciate liga-
ment transection with partial medial menisectomy (ACLT+pMMx)
to mimic a joint instability model and another (n=8) received an
intra-articular injection of monoiodoacetate (MIA) (3mg/30μl) as
an inﬂammatory pain model. After recuperation (2 days MIA, 5
days ACLT+pMMx), the tests were performed for four consecu-
tive weeks. After the behavioural measurement period, rats were
sacriﬁced. Both knee joints were collected for histological assess-
ment as well as spinal cord lumbar enlargements for neuropeptide
analysis by HPLC/ESI/MS/MS. Repeated measure analysis of
variances (linear model) followed by a sequential Bonferonni cor-
rection were performed for gait analysis parameters and von Frey
results.
Results: No signiﬁcant differences were observed in the gait
speed between the three groups at each time point and in com-
parison with the baseline values. Changes in dynamic gait pa-
rameters were observed starting on the ﬁrst day of testing, post
OA-induction, in both models. A tendency towards stabilization
in the surgical model was observed with parameters returning
near to the baseline values (ex. swing phase duration, the swing
speed and the ratio between the stance phase and the com-
plete stepcycle duration). These observations were seen in both
hind limbs, with no statistical differences between the ipsilateral
and the contralateral limbs. Conversely, in the MIA model sig-
niﬁcant changes remained in the injured limb compared to the
contralateral limb in the swing phase duration (p<0.02) and the
swing speed (p0.2). With von Frey ﬁlaments, mechanical sensi-
tisation was observed in the ipsilateral limb of the MIA model
only (p<0.0001). Neuropeptide analysis demonstrated signiﬁcant
increase in CGRP concentrations in both models with 5803±1520
pmol/g and 4651±586pmol/g in the ACLT+pMMx and MIA models
